Rapid7, Inc. (RPD) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reflects a positive outlook with strong gross margins, strategic investments in AI and international markets, and a promising partnership with Microsoft. Despite conservative guidance, the company shows potential for growth, particularly in MDR and Exposure Command. The Q&A highlights management's confidence in their strategic direction, though cautious about forecasting due to deal variability. The market cap suggests moderate volatility, but the positive elements likely outweigh concerns, forecasting a positive stock price movement (2% to 8%) over the next two weeks.
Key Financial Performance
ARR (Annual Recurring Revenue) $838 million, growing 2% year-over-year. The growth was driven predominantly by a 2% increase in ARR per customer. However, there was timing variability within the large deal pipeline.
Revenue $218 million, growing 2% year-over-year. This exceeded the guided range, driven by product subscription revenue growth and international revenue growth of 8%.
Operating Income $37 million, above the guidance range. This was driven by natural leverage in the business and timing of spend.
Free Cash Flow $30 million generated in the quarter. This contributed to a year-to-date free cash flow of $98 million, driven by strong operational performance.
Product Subscription Revenue $210 million, growing 2% year-over-year. Growth was supported by enhancements in product capabilities.
Professional Services Revenue Declined year-over-year, consistent with the decision to deemphasize certain lower-margin services.
International Revenue Represented 25% of total revenue and grew 8% year-over-year, driven by increased adoption in international markets.
Gross Margin Product gross margin was 75%, and total gross margin was 73%. These margins were supported by operational efficiencies.
Sales and Marketing Expenses 33% of revenue, slightly above the prior year's 31%, reflecting targeted growth investments.
R&D and G&A Expenses R&D expenses were 17% of revenue, and G&A expenses were 6% of revenue, consistent with prior year levels.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
AI-powered SOC vision: Rapid7 is innovating on its AI-powered SOC vision, which integrates AI into security operations to enhance situational awareness and remediation outcomes.
Command Platform: The platform unifies exposure management and threat detection response, providing integrated solutions for risk and threat management.
MDR for Microsoft: A new solution integrating Rapid7's SOC expertise with Microsoft Defender to enhance detection and response capabilities.
AI-generated risk intelligence: New feature in Rapid7's Remediation Hub to prioritize and remediate security threats faster.
Market validation: Recent wins, such as a six-figure deal with a Tier 1 public university, validate Rapid7's platform approach and leadership in the market.
Partnership with Microsoft: Expanding partnership to simplify and strengthen detection and response capabilities across Microsoft environments.
Leadership changes: New Chief Commercial Officer Allan Peters and incoming CFO Rafe Brown to drive operational alignment and growth.
Operational focus: Allan Peters is implementing changes to better align resources and incentives for growth in 2026, particularly in the MDR business.
ARR target adjustment: Reduced 2025 ARR target to reflect higher confidence outlook and rebuild investor confidence.
Focus on MDR: Accelerating growth transition towards a scaled market-leading MDR position for 2026.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Timing variability in large deal pipeline: The company continues to experience timing variability within its large deal pipeline, which has affected quarterly deal timing and overall growth performance.
Falling short of ARR guidance: The company acknowledges falling short of the ARR guidance provided in recent history, which has impacted investor confidence.
Longer competitive deal cycles: Larger platform consolidation opportunities naturally lead to longer, more competitive deal cycles, affecting growth performance.
Operational changes creating forecasting variance: Operational changes, including leadership transitions and resource realignment, may create higher near-term forecasting variance.
Customer spending environment challenges: The customer spending environment is challenged by additional scrutiny, particularly in large deals.
Execution shortcomings in Exposure Command expansion: The company has fallen short of its goals in expanding its Exposure Command customer base, which is seen as an execution shortcoming.
Regulatory pressures: Regulatory pressures for compliance and reporting are amplifying demand for integrated exposure and detection programs, which could pose challenges if not adequately addressed.
Deemphasis on lower-margin services: The decision to deemphasize certain lower-margin professional services has led to a decline in professional services revenue.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
ARR (Annual Recurring Revenue) Target for 2025: The company has reduced its 2025 ARR target to reflect a higher confidence outlook, embedding a discount for potential impacts of operational changes and seasonal budget opportunities.
Growth Focus for 2026: Operational changes are being implemented to better align resources and incentives for growth in 2026 and beyond, particularly in the MDR (Managed Detection and Response) business, which is more than half of ARR and continues to grow double digits.
AI-Powered Security Operations: The company is focusing on scaling its AI-driven security operations command platform, integrating exposure management and detection and response capabilities to drive growth.
Revenue Guidance for Q4 2025: Revenue is expected to be in the range of $214 million to $216 million.
Full-Year 2025 Revenue Guidance: Revenue guidance for the full year is tightened to $856 million to $858 million, representing year-over-year growth of 1% to 2%.
Profitability Guidance for 2025: Operating income guidance for the full year is raised to $130 million to $135 million, representing an operating margin of 15% to 16%. Non-GAAP net income per share is expected to be $2.02 to $2.09.
Free Cash Flow Guidance for 2025: The company reiterates its full-year free cash flow target range of $125 million to $135 million.
Q4 2025 Profitability Guidance: Non-GAAP operating income is expected to be between $25 million and $30 million, and non-GAAP net income per share is expected to be $0.37 to $0.44.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you talk about the economic model of MDR and its impact on margins?
A:MDR operates at a higher gross margin and overall profitability compared to average MDR companies. This is due to investments in automation and AI capacity, which allow for high-quality, efficient, and profitable operations. The company has been deliberate in building a high-margin business over time.
Q:Can you parse the success seen internationally versus domestically?
A:International revenue accounts for 25% of total revenue and is growing faster than the overall business. Investments have been made to align sales processes across regions, and there is still significant growth potential in both North America and international markets.
Q:How do you address concerns about pricing pressure and competition in the MDR business?
A:MDR is growing double digits, and the company has been cautious about growth to maintain gross margins. The competitive positioning is strong, offering AI-driven SOC services that combine technology and people, resulting in high retention rates and economic efficiency.
Q:How should we think about the growth versus profitability algorithm for calendar '26?
A:The company has built an efficient business and is making investments now to capitalize on opportunities, such as the partnership with Microsoft. These investments aim to scale profitability in the coming years while leveraging operational changes and sales processes.
Q:Can you talk about the large deal pipeline and its impact on Q4 outlook?
A:The company has taken a conservative approach to Q4 guidance, focusing on high-confidence outlooks. Large deals take longer to close, and the company is rebaselining processes to improve precision in forecasting.
Q:What is the Chief Commercial Officer doing to align resources behind MDR and other opportunities?
A:The CCO is standardizing operating procedures, focusing on upgrade opportunities, and aligning the sales force around the AI-managed SOC platform to unlock growth opportunities.
Q:What were the key criteria in selecting the new CFO, Rafe?
A:The company sought an operationally minded CFO to align sales, business models, and product strategies for sustained growth. Rafe was chosen for his ability to scale processes and drive predictable economic growth.
Q:How valuable is the traditional VM piece to the SIEM, MDR side of the business?
A:The company is transitioning from traditional on-premise VM to strategic value-added workloads like MDR and managed services. The focus is on extending MDR capabilities to manage risk, compliance, and red teaming.
Q:What are your expectations from the Microsoft partnership?
A:The partnership starts with technology integration and includes collaboration with Microsoft's go-to-market teams. It aims to manage Microsoft's defender ecosystem at scale, providing growth opportunities for both companies.
Q:How comfortable are you with visibility around the pipeline and close rates?
A:The company acknowledges a range of outcomes and is working to standardize processes for managing larger deal cycles. Improvements are expected as the new CCO gains experience.
Q:What is the underlying momentum of the business despite conservatism in guidance?
A:The pipeline remains strong, but the company is cautious about forecasting due to variability in deal closures. The focus is on providing a high-confidence outlook.
Q:What does the data show about Exposure Command's performance?
A:Exposure Command deals have larger ASPs, over double the legacy VM ASPs, but have longer deal cycles. The focus has been on upgrades rather than new customer acquisition.
Q:What investments are required to support the Microsoft integration?
A:No incremental resources are needed; existing resources are being realigned. The focus is on training and enabling the sales team to capitalize on the partnership's opportunities.
Q:How has gross churn trended, and what are the expectations for retention?
A:Gross churn has been stable and in line with expectations. As the business mix shifts towards MDR, retention rates are expected to improve due to longer deal terms and strategic value.
Q:Review of Unclear Management Responses
A:Management avoided providing precise details on the range of outcomes for Q4 and the exact impact of pipeline variability. They also did not specify the exact uplift in ARR guidance or the precise timeline for Exposure Command's ramp-up.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI SOC
AI risk
AI security
Chief Financial
Command Platform
Detection Response
Financial Officer
Managed Detection
Microsoft
SIEM
SOC security
SOC vision
action
alignment
announcement
automation
awareness
change
customer environment
detection response
engine
example
experience SOC
expert AI
expertise AI
exposure detection
organization detection
platform exposure
platform value
position market
program
recognition
remediation threat
tech stack
threat response
RPD Transcript
Rapid7, Inc. (RPD) Q1 2026 Earnings Call Transcript
Positive5-5
The earnings call summary shows strong financial performance with a 15% increase in revenue, improved gross margins, and significant growth in operating income, net income, and free cash flow. Despite the absence of strategic updates and risk discussions, the financial metrics are robust, indicating positive sentiment. Given the small-cap nature of the company, these results are likely to positively impact the stock price in the short term.
Rapid7, Inc. (RPD) Q4 2025 Earnings Call Transcript
Unknown2-10
The earnings call presents mixed signals. While there are positive aspects like the focus on AI-powered operations and a strong position to address debt maturity, the lack of full-year ARR guidance and unclear management responses on certain issues introduce uncertainties. The company's strategic focus areas and potential growth in MDR and exposure management are promising, but the ongoing churn and ARR decline concerns offset these positives. Given the market cap, the stock is likely to see a neutral reaction, with a possible slight tilt towards positive if growth strategies gain traction.
Rapid7, Inc. (RPD) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call reflects a positive outlook with strong gross margins, strategic investments in AI and international markets, and a promising partnership with Microsoft. Despite conservative guidance, the company shows potential for growth, particularly in MDR and Exposure Command. The Q&A highlights management's confidence in their strategic direction, though cautious about forecasting due to deal variability. The market cap suggests moderate volatility, but the positive elements likely outweigh concerns, forecasting a positive stock price movement (2% to 8%) over the next two weeks.
Rapid7, Inc. (RPD) Q2 2025 Earnings Call Transcript
Unknown8-7
The earnings call reflects mixed signals: the company shows strong product development and strategic initiatives, particularly in AI and partnerships, which are positive indicators. However, the lowered ARR guidance, despite a healthy pipeline and Q2 results, introduces uncertainty. The cautious approach to guidance reflects strategic deal cycles, but vague responses in the Q&A, especially regarding the India SOC and ARR adjustments, suggest potential execution risks. Given the market cap of $2.66 billion, the stock is likely to experience a neutral reaction, with minor fluctuations within the -2% to 2% range.
RPD Slides
Rapid7 Q4 2025 slides: Flat growth and conservative 2026 outlook despite margin gains2026-02-10
Rapid7 Q3 2025 slides: Margin expansion continues amid slowing growth2025-11-04
Rapid7 Q2 2025 slides: Margin expansion offsets slowing growth in security market2025-08-07
Rapid7 Q1 2025 slides reveal margin expansion amid moderating growth2025-05-12
RPD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
